Clinical Trial of Aesculus Hippocastanum and Associations Versus Diosmina and Hesperidina in Chronic Venous Insuficiency
Clinical Study of Non-inferiority Between Aesculus Hippocastanum 50mg, Polygonum Acre 10mg, Smilax Pepyracea 40mg, Rutin 20mg Versus Diosmin 450mg and Hesperidin 50mg Tablets in Chronic Venous Insufficiency After 3 Months of Therapy
Sponsor: Fundação Educacional Serra dos Órgãos
Listed as NCT06579482, this PHASE4 trial focuses on Chronic Venous Insufficiency and remains completed. Sponsored by Fundação Educacional Serra dos Órgãos, it has been updated 2 times since 2024, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
2 versions recorded-
Feb 2026 — Present [monthly]
Completed PHASE4
Status: Recruiting → Completed
-
Sep 2024 — Feb 2026 [monthly]
Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Fundação Educacional Serra dos Órgãos
For direct contact, visit the study record on ClinicalTrials.gov .